332 related articles for article (PubMed ID: 24430181)
1. Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy.
D'Amico G; Korhonen EA; Anisimov A; Zarkada G; Holopainen T; Hägerling R; Kiefer F; Eklund L; Sormunen R; Elamaa H; Brekken RA; Adams RH; Koh GY; Saharinen P; Alitalo K
J Clin Invest; 2014 Feb; 124(2):824-34. PubMed ID: 24430181
[TBL] [Abstract][Full Text] [Related]
2. Tie1 controls angiopoietin function in vascular remodeling and inflammation.
Korhonen EA; Lampinen A; Giri H; Anisimov A; Kim M; Allen B; Fang S; D'Amico G; Sipilä TJ; Lohela M; Strandin T; Vaheri A; Ylä-Herttuala S; Koh GY; McDonald DM; Alitalo K; Saharinen P
J Clin Invest; 2016 Sep; 126(9):3495-510. PubMed ID: 27548530
[TBL] [Abstract][Full Text] [Related]
3. The Orphan Receptor Tie1 Controls Angiogenesis and Vascular Remodeling by Differentially Regulating Tie2 in Tip and Stalk Cells.
Savant S; La Porta S; Budnik A; Busch K; Hu J; Tisch N; Korn C; Valls AF; Benest AV; Terhardt D; Qu X; Adams RH; Baldwin HS; Ruiz de Almodóvar C; Rodewald HR; Augustin HG
Cell Rep; 2015 Sep; 12(11):1761-73. PubMed ID: 26344773
[TBL] [Abstract][Full Text] [Related]
4. Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival.
Yuan HT; Venkatesha S; Chan B; Deutsch U; Mammoto T; Sukhatme VP; Woolf AS; Karumanchi SA
FASEB J; 2007 Oct; 21(12):3171-83. PubMed ID: 17504972
[TBL] [Abstract][Full Text] [Related]
5. Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands.
Seegar TC; Eller B; Tzvetkova-Robev D; Kolev MV; Henderson SC; Nikolov DB; Barton WA
Mol Cell; 2010 Mar; 37(5):643-55. PubMed ID: 20227369
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia reduces endothelial Ang1-induced Tie2 activity in a Tie1-dependent manner.
Yun JH; Lee HM; Lee EH; Park JW; Cho CH
Biochem Biophys Res Commun; 2013 Jul; 436(4):691-7. PubMed ID: 23770419
[TBL] [Abstract][Full Text] [Related]
7. Genetic dissection of tie pathway in mouse lymphatic maturation and valve development.
Shen B; Shang Z; Wang B; Zhang L; Zhou F; Li T; Chu M; Jiang H; Wang Y; Qiao T; Zhang J; Sun W; Kong X; He Y
Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1221-30. PubMed ID: 24764452
[TBL] [Abstract][Full Text] [Related]
8. Endothelial TIE1 Restricts Angiogenic Sprouting to Coordinate Vein Assembly in Synergy With Its Homologue TIE2.
Cao X; Li T; Xu B; Ding K; Li W; Shen B; Chu M; Zhu D; Rui L; Shang Z; Li X; Wang Y; Zheng S; Alitalo K; Liu G; Tang J; Kubota Y; He Y
Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):e323-e338. PubMed ID: 37317851
[TBL] [Abstract][Full Text] [Related]
9. Effects of angiopoietins-1 and -2 on the receptor tyrosine kinase Tie2 are differentially regulated at the endothelial cell surface.
Hansen TM; Singh H; Tahir TA; Brindle NP
Cell Signal; 2010 Mar; 22(3):527-32. PubMed ID: 19922791
[TBL] [Abstract][Full Text] [Related]
10. The molecular balance between receptor tyrosine kinases Tie1 and Tie2 is dynamically controlled by VEGF and TNFα and regulates angiopoietin signalling.
Singh H; Hansen TM; Patel N; Brindle NP
PLoS One; 2012; 7(1):e29319. PubMed ID: 22235284
[TBL] [Abstract][Full Text] [Related]
11. Tie2-dependent neovascularization of the ischemic hindlimb is mediated by angiopoietin-2.
Lekas M; Lekas P; Mei SH; Deng Y; Dumont DJ; Stewart DJ
PLoS One; 2012; 7(9):e43568. PubMed ID: 23049737
[TBL] [Abstract][Full Text] [Related]
12. Roles of the receptor tyrosine kinases Tie1 and Tie2 in mediating the effects of angiopoietin-1 on endothelial permeability and apoptosis.
Milner CS; Hansen TM; Singh H; Brindle NP
Microvasc Res; 2009 Mar; 77(2):187-91. PubMed ID: 18848573
[TBL] [Abstract][Full Text] [Related]
13. Preclinical validation of a novel metastasis-inhibiting Tie1 function-blocking antibody.
Singhal M; Gengenbacher N; La Porta S; Gehrs S; Shi J; Kamiyama M; Bodenmiller DM; Fischl A; Schieb B; Besemfelder E; Chintharlapalli S; Augustin HG
EMBO Mol Med; 2020 Jun; 12(6):e11164. PubMed ID: 32302470
[TBL] [Abstract][Full Text] [Related]
14. Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor-tyrosine kinase Tie2.
Marron MB; Singh H; Tahir TA; Kavumkal J; Kim HZ; Koh GY; Brindle NP
J Biol Chem; 2007 Oct; 282(42):30509-17. PubMed ID: 17728252
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases.
Singh H; Milner CS; Aguilar Hernandez MM; Patel N; Brindle NP
Cell Signal; 2009 Aug; 21(8):1346-50. PubMed ID: 19376222
[TBL] [Abstract][Full Text] [Related]
16. Endothelial-specific Notch blockade inhibits vascular function and tumor growth through an eNOS-dependent mechanism.
Patenaude A; Fuller M; Chang L; Wong F; Paliouras G; Shaw R; Kyle AH; Umlandt P; Baker JH; Diaz E; Tong J; Minchinton AI; Karsan A
Cancer Res; 2014 May; 74(9):2402-11. PubMed ID: 24599126
[TBL] [Abstract][Full Text] [Related]
17. Differential inhibition of tumor angiogenesis by tie2 and vascular endothelial growth factor receptor-2 dominant-negative receptor mutants.
Stratmann A; Acker T; Burger AM; Amann K; Risau W; Plate KH
Int J Cancer; 2001 Feb; 91(3):273-82. PubMed ID: 11169947
[TBL] [Abstract][Full Text] [Related]
18. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization.
Takagi H; Koyama S; Seike H; Oh H; Otani A; Matsumura M; Honda Y
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):393-402. PubMed ID: 12506101
[TBL] [Abstract][Full Text] [Related]
19. Cyclic strain regulates the Notch/CBF-1 signaling pathway in endothelial cells: role in angiogenic activity.
Morrow D; Cullen JP; Cahill PA; Redmond EM
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1289-96. PubMed ID: 17395855
[TBL] [Abstract][Full Text] [Related]
20. NERF2, a member of the Ets family of transcription factors, is increased in response to hypoxia and angiopoietin-1: a potential mechanism for Tie2 regulation during hypoxia.
Christensen RA; Fujikawa K; Madore R; Oettgen P; Varticovski L
J Cell Biochem; 2002; 85(3):505-15. PubMed ID: 11967990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
